We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

Hot Biotech Stocks That Deserve Your Attention In August 2021

1 28 1
11.08.2021

Finding hot industries is always a favored research topic whether you’re trading penny stocks or higher-priced names. Right now, a few of the hottest to watch this year are biotechnology and healthcare.

While you might think that coronavirus vaccine stocks take the cake when it comes to these sectors, other trends have rapidly emerged and deserve some extra attention right now.

In particular, new advancements in oncology treatment and cancer research have taken the spotlight away from 2020’s COVID trend. While the likes of Novavax (NASDAQ: NVAX), Moderna (NASDAQ: MRNA), and Pfizer (NYSE: PFE) remain topics of discussion, they aren’t commanding all headlines all the time like we saw last year. In fact, some of the better-known vaccine companies like BioNTech (NASDAQ: BNTX) are spreading their wings in 2021.

This quarter, the company acquired a treatment platform and manufacturing facility from Gilead’s (NASDAQ: GILD) Kite subsidiary. Specifically, BioNTech procured Kite’s neoantigen TCR cell therapy R&D platform along with its Maryland-based manufacturing facility.

“The development of individualized cancer therapies is at the core of our work at BioNTech. The acquisition of the Kite facility and its individualized TCR platform allows us to accelerate the clinical development of our cell therapies in the U.S. and advance at the forefront of individualized cell therapies.”

You also can’t forget other big biotech M&A from Sanofi (NASDAQ: SNY). If you remember our article, “Top Biotech Penny Stocks On Robinhood To Watch This Week,” we discussed Sanofi and its strengthening relationship with a former penny stock, Translate Bio Inc. (NASDAQ: TBIO). That evolved into a $3.2 billion buyout of Translate, a 30% premium at the time of the announcement. Thanks to this (and plenty more), biotech stocks have come into focus this year. Today we’ll take a look at a list of former penny stocks that have now grown into much larger companies. Furthermore, they’ve all got upcoming potential catalysts to be well aware of especially in the near term.

With attention on oncology treatment stocks this quarter, GT Biopharma and its novel treatment platform have come into focus. Traditional treatments for cancer like chemotherapy are quickly taking a back seat to what’s being called “targeted treatment.” Popular platforms like CAR-T have emerged as the first iteration of this treatment type. The big picture on things like CAR-T is that it utilizes a patient’s own biology to treat cancer. But it doesn’t come without its downsides, including adverse side-effects as well as high-ticket costs.

GT Biopharma has focused on addressing both of........

© Entrepreneur


Get it on Google Play